SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001326190-23-000028
Filing Date
2023-05-11
Accepted
2023-05-11 16:06:13
Documents
57
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alt-20230331x10q.htm   iXBRL 10-Q 929517
2 EX-31.1 alt-20230331xex31d1.htm EX-31.1 11935
3 EX-31.2 alt-20230331xex31d2.htm EX-31.2 11778
4 EX-32.1 alt-20230331xex32d1.htm EX-32.1 6755
5 EX-32.2 alt-20230331xex32d2.htm EX-32.2 6885
6 GRAPHIC alt-20230331x10q002.jpg GRAPHIC 16725
  Complete submission text file 0001326190-23-000028.txt   4438098

Data Files

Seq Description Document Type Size
7 EX-101.SCH alt-20230331.xsd EX-101.SCH 34528
8 EX-101.CAL alt-20230331_cal.xml EX-101.CAL 38272
9 EX-101.DEF alt-20230331_def.xml EX-101.DEF 123012
10 EX-101.LAB alt-20230331_lab.xml EX-101.LAB 328910
11 EX-101.PRE alt-20230331_pre.xml EX-101.PRE 222295
51 EXTRACTED XBRL INSTANCE DOCUMENT alt-20230331x10q_htm.xml XML 681422
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 23910953
SIC: 2834 Pharmaceutical Preparations